Trial Profile
The Effect of Rosuvastatin on Immune Activation Markers in treatment-naive HIV-Positive Patients; A Randomized Placebo-Controlled Trial.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Jun 2010
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- Acronyms StatHIV
- 11 Jun 2010 New trial record